Sore mandible. Bisphosphonate-associated osteonecrosis.
Damm
Douglas D
DD
Department of Oral Health Sciences, Division of Oral Pathology, College of Dentistry, University of Kentucky, Lexington, USA.
Fantasia
John E
JE
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D007262:Infusions, Intravenous; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis; D014081:Tooth Extraction / Q000009:adverse effects; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid